Eurobio Scientific reported revenue results for the year 2021. For the year, the company reported revenue of 184.1 million compared to $188.5 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.2 EUR | +2.16% |
|
+2.90% | -13.73% |
Jun. 24 | Proteomics International Laboratories Taps French Distributor for Diabetic Kidney Disease Test | MT |
May. 08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.73% | 156M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- ALERS Stock
- News Eurobio Scientific
- Eurobio Scientific Reports Revenue Results for the Year 2021